i think the ad is a bit above the level of a local auto mall production. certainly made for cable quality. its ok as an ad. a lot of verbiage and not a lot of education as to why it is different than commercial ginger ales. i think that is giant missed opportunity. however, it really features CHRIS REED!! and that is important because its CHRIS REEDS company. so the important thing was accomplished. i can not comment on anything about spend or selected channels. you see the huge problem with virgils and reeds disparate lines. no mention of virgils; another missed opportunity and not how i would build the brand. but whatever. CHRIS REED everybody! lets open on grey pony tail and pull away and ...... cut.
i think if there was a marketing plan in place, advertising is a good strategy. i do not believe there is a marketing plan in place. KOMBUCHA!!! SQUIRREL! GINGER!! it is all over the map. they need a great marketing mind to build the brands. they need to distinguish what is different from current product. that they utterly failed to do. and i dont get why they missed that point.
in the absence of a business plan or creative leadership, it is nice to ponder how a 15,000 shares will impact company valuation. this is why the stock price hasn't moved in a decade. what if they change to LED lights in mens' room? that will save some money too.
i will not suggest this stock as investment that can be held for long term, until there is a dramatic change in the business where growth is a priority and shareholders are considered important. up til now, this has largely been a company run by the executives for the executives.
Myriad Genetics, Inc. (MYGN) went down 3% yesterday after the company’s President and CEO Peter D. Meldrum sold 24,000 of his shares for $39.50 a piece, on the same day that he exercised a non-qualifying stock option to buy the same number of shares for $9.04 apiece.
Myriad share price decreased by $1.30 after the $948,000 deal was executed.
Chief Scientific Officer Jerry Lanchbury executed a stock sale of 20,000 shares at an average price of $39.85. This sale landed yet another blow to investors’ confidence in the company.
Myriad Genetics is a leading molecular diagnostic company, and has a market capitalization of $2.93 billion. Its fundamentals have been very strong over the years; it has consistently beat the Street’s sales and earnings estimates for the past eight quarters.
The company reported earnings per share (EPS) of $0.48 for the first quarter of fiscal 2014 (1QFY14), and beat Reuters’s EPS estimate by three cents. It is expected that FY14 revenues will increase 26.6% to $776.3 million. EPS is projected to rise 35.3% to $2.40.
The company has laid out a strategy to expand in the hereditary-cancer treatment market, and is launching new life-saving products. The majority of growth has come from the drug market, particularly in the oncology and women’s health businesses.
Of 21 analysts covering the stock, seven have rated it a Buy, and 12 a Hold. Currently, the stock is trading at $39.11, and according to analysts the target price is $40.17, reflecting an upside of 2.71%.
SO, my concern that the management was complacent is confirmed. i did not know medlrum was dumping stock and printing himself new shares at my expense. thanks peter for going to work today. i so appreciate it. and this is why its taken more than 13 years for the stock to not reach new highs. management doesnt care much since they can print their own cash. maybe it is part of the new corporatist fascism which rules the country. maybe he just doesnt care much about shareholders
i do not like the way drug companies have taken advertising direct to consumer. the fda has made it a comical farce. advertise to doctors in a responsible way. not consumers who the drug company is trying to fool and pressure. however, mygn shoudl absolutely be advertising as the gold standard in breast cancer testing. patients will get fooled into less effective and cheaper tests by their doctors and insurers. fully appropriate. yet they dont. we removed your breasts and saved ourselves $300 using labcorp's pretty good test. shhh. with a more aggressive management looking to expand services, they would have been a household name. they loved ms. jolie. loooooved. so how do you squander that opportunity to run the table? they are doing a good job, but they can improve in so many areas that they have neglected for 15 years. i hope that they have regained some self-confidence at this point.
this could be a global 50-100 billion dollar company that does great things for humanity. however, they seem to be aiming low and lack aggressiveness. a new ceo might be in order before a drug company buys them for cashflow and puts them on a back burner. they need to stop messing around and decide to set the global bar for genetic testing in an effective, ethical way.
dumbest thing i have ever seen. where is carol?
The fundamentals alone will dictate a price of $300 within 5 yrs. or so; the shorts will make it happen much sooner.
yes, the earnings will go up a factor of 1 every six months. sure.
thoughtful answer manuel. of course the company has people who like the product and buy it. however, they are not on trend and their current attempts to follow the natural trend will fail. the demo for 35 yo men drinking soda is collapsing. and the gourmet section of the market is not their sector. they suggest they are premium. relative to coke or pepsi they are premium. but they are a premium soda at the walmart level. walmart is notorious for pressuring margins of vendors. sometimes to the point of breaking the vendor. at this stage that is likely where walmart has jones. and it is not likely that they can make money on walmart sales. it is a bad scene.
the new flavor introduction is an example of how lost the company is. it is like jc penney buying new manikins and thinking they did something vital. so too the michigan nonsense. they are playing small ball and hoping the ongoing losses minimize to get to a point where they are almost breaking even. it is good for employees. for investors, it will be enshrine the disaster.
i am glad you like what she is doing. what products do you order? i assume you are ordering from the website because there is no place to purchase near you. i have no doubt the web site is user friendly to order from. it is 2014 after all. empty fields and links that have empty pages, details of descriptions missing, is what i was pointing out. CFOs tend not to leave a public company in the middle of a great boon in business. i think she saw no further future and took a different opportunity. the market seems to agree. but please tell me what products they make that you are willing to pay $2 a soda for and wait for delivery? why are you a fan?
you miss the point. they dont have anything of impact to announce so they are issuing silly and meaningless PRs. this is the busy season and the stock dropped on concern over growth. the lack of news confirms the concerns.
make no mistake, if this earnings cc is the same barrel of excuses (carrie quit for a reason), then the stock is going back to 20 cents this year. there appears to be little reason at this point for the doors to be open. unless soda for children becomes a growth category again. the naturals line is a joke and should be entirely discounted, since they can not even be bothered to say what is in it. the most basic concepts of selling a product? 25 people and the website looks like the have a 12 year old intern designer and webmaster.
what a sad, sad mess. but hey, you see all the positive press and fan enthusiasm on this board and from bloggers. a real viral success story. (sarcasm - there is no buzz, no viral anything, just sad reviews from years ago on youtube, google, etc.. )
ukraine is a big future market for them. like canada is now (sarcasm). nice old article on jones in the seattle paper on how they screwed up. nothing has changed.
you utterly miss the point. why is reed releasing a PR to state that a distributor in western north carolina that carries their products is expanding their distribution in the area? it is so trivial and inconsequential, yet they saw the need to release some news, without having anything to announce of even mild impact? in a company with a supposed 20% yoy and 100% kombucha yoy, the last thing i would expect is such news. since the concern among investors has been slowing gorwth, such a pr would indicate that little is happening of note in the business in their busiest season. my comments didnt cause a 50% crash in the stock, chris reed's comments did. the earnings announcements did.
like todays, i think it is a sign of trouble. it smells of desperation. you announced an expansion in a part of one state where distribution already underway with an existing distributor? what did that cost - a grand to release? maybe everyone is just chilling for the summer, waiting for the sweepstakes winner to be announced. btw, the expansion of what? to where? to what effect? why? just so amateur. is there a professional responsible for this nonsense?
stunning salaries for the executives of this company that can not make a profit. $125k a location is the valuation now? each store is worth the same as a nice bmw. yet, the ceo makes 800K? lol. postpone bankruptcy as long as possible to milk the cow.
imagine a government administrator saying that too much money in our society is going into medical and health technology and research. that is what she did. is the weapons sector underfunded now janet? should we rotate? so the banks are short biotech. janet does their bidding. Elizabeth Warren 2016.
you dont understand patent law very well. you also dont understand business or product integrity very well. the product has to manufactured to near pharmacy level quality controls. you think a qsr is going make their own to save a few dollars? you think a chinese company is going to knock it off and win accounts? there is no barrier to entry in making soda and a moron can actually make it. go try and make money making soda commercially.
i think the results will be up a little bit and the clear slowing growth will have a re-pricing effect on the stock to the low 40s and a more reasonable pe. i think a pe of 15 - 16 is in the offing.
honestly, that is not much of a research budget. it is a micro cap research budget. how much is spent on battery research by comparison. ford spends 8 billion on RD. so how likely is it that if capacitors are critical technology, ford is going to be out-innovated by a company spending 22 million? i do think it odd that mxwl was never bought out by a big player in the electronics space. GE, for example. somehow mxwl was overlooked. that is strange.
got it. just to be clear, the craft soda market is going to explode. just like beer did. those trends are in place. however, jones is not craft. jones is essentially mass produced, artificially colored and flavored children's soda. read the ingredients. i would not give this stuff to a child i cared about. i would educate them away from such products. note the collapsing sales. i mean utter collapse. this is a novelty company, not a beverage company. it is a photo on a bottle company. a halloween novelty company. go read the on line review of stripped/natural.
put some decent stuff in your store. oh, and sell frozen junior mints and mochi ice cream. you will be unique and make some money. mochi baby.
oh no! the new coke of the soda market is starbucks. since the reeds brand was probably deemed to be of little value. i would guess they looked at reeds and decided to create their own in-house products and expertise.
SEATTLE, June 23, 2014 – Just in time for the warm weather, Starbucks (NASDAQ: SBUX) tomorrow will unveil a selection of new refreshing beverages, expanding its cold beverage portfolio with the addition of Fizzio™ Handcrafted Sodas and Teavana® Shaken Iced Teas. Fizzio™ Handcrafted Sodas are carbonated fresh and debut in three classic flavors with a Starbucks twist – Spiced Root Beer, Golden Ginger Ale and Lemon Ale. Each Fizzio soda contains no artificial flavors, no preservatives or high fructose corn syrup and has 100 calories or less in a Grande (16 fl. oz.). The new Fizzio sodas will be available at select Starbucks locations in the U.S. **
Customers can also experience a fresh take on iced tea from Teavana at Starbucks with new and returning favorites this summer. The new Teavana® Blackberry Mojito Tea Lemonade and returning favorite Teavana® Peach Green Tea Lemonade will be available nationwide and in Canada beginning June 24.
“We have heard from our customers that they’re looking for more refreshing, cold beverages, especially during the warm summer months,” said Cliff Burrows, group president, U.S., Americas and Teavana. “Fizzio Handcrafted Soda is unlike any soda in the marketplace because it’s handcrafted and made-to-order each time. The addition of Fizzio and Teavana Iced Teas gives our customers more refreshing beverage choices made with the premium ingredients they expect from Starbucks.”
Classic Flavors with a Twist
Fizzio™ Handcrafted Sodas are rooted in classic flavors, but with a signature twist to deliver an experience unlike other sodas. The soda creation begins with batch brewing real, premium ingredients to develop complex and layered flavors, and each Fizzio beverage is individually handcrafted for each customer.
let me clarify. essentially all the analysts are estimating a decline in earnings in 2015. only the company itself has estimated earnings are increasing, not decreasing. it will be truly up to the next conference call to provide critical forward guidance. the shorts are betting a billion dollars that they say that during the transition to myrisk earnings will fall and increased competition will further impact earnings. it is a sizable bet and one they must have a lot of confidence in to be so complacent. true reversal support ultimately is around $20. and dont kid yourself, if guidance is poor, it can trade at $20.